Biblio

Author Title Type [ Year

]

Filters: Author is Schmitt, Anna [Clear All Filters]

2022

Younan N, Soussain C, Choquet S, Cassoux N, Touitou V, Schmitt A, Chinot O, Obéric L, Damaj G, Houot R, et al. Isolated intraocular relapses of primary cerebral lymphomas: AN LOC NETWORK STUDY. Hematol Oncol. 2022.

Lesueur P, Damaj G, Hoang-Xuan K, Roland V, Schmitt A, Chinot O, Fabbro M, Agape P, Chabrot CMoluçon, Chebrek S, et al. Reduced-dose WBRT as consolidation treatment for patients with primary CNS lymphoma: a LOC-network study. Blood Adv. 2022.

2019

Manson G, Mear J-B, Herbaux C, Schiano J-M, Casasnovas O, Stamatoullas A, Deau B, Schmitt A, Garnier G, Regny C, et al. Long-term efficacy of anti-PD1 therapy in Hodgkin lymphoma with and without allogenic stem cell transplantation. Eur J Cancer. 2019;115:47-56.

2015

Dietlein F, Kalb B, Jokic M, Noll EM, Strong A, Tharun L, Ozretić L, Künstlinger H, Kambartel K, Randerath WJ, et al. A Synergistic Interaction between Chk1- and MK2 Inhibitors in KRAS-Mutant Cancer. Cell. 2015;162(1):146-159.